Parallel Advisors, LLC Cerus Corp Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$1.5 - $3.07 $828 - $1,694	-552 Reduced 58.6%	390 $0
Q3 2023 Nov 13, 2023	SELL	$1.5 - $3.07 $828 - $1,694	-552 Reduced 58.6%	390 $0
Q2 2023 May 20, 2024	SELL	$1.79 - $2.9 $893 - $1,447	-499 Reduced 34.63%	942 $2,000
Q2 2023 Aug 04, 2023	SELL	$1.79 - $2.9 $893 - $1,447	-499 Reduced 34.63%	942 $2,000
Q1 2023 May 20, 2024	BUY	$2.65 - $3.81 $3,818 - $5,490	1,441 New	1,441 $4,000
Q3 2017 Nov 15, 2017	BUY	$2.22 - $2.73 $3,199 - $3,933	1,441 New	1,441 $5,000
Q3 2017 Nov 14, 2017	SELL	$2.22 - $2.73 $2,333 - $2,869	-1,051 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	1,051	1,051 $2,000

160

146M

48.6K

8.7K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $271M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.